JP2019509318A5 - - Google Patents

Download PDF

Info

Publication number
JP2019509318A5
JP2019509318A5 JP2018549896A JP2018549896A JP2019509318A5 JP 2019509318 A5 JP2019509318 A5 JP 2019509318A5 JP 2018549896 A JP2018549896 A JP 2018549896A JP 2018549896 A JP2018549896 A JP 2018549896A JP 2019509318 A5 JP2019509318 A5 JP 2019509318A5
Authority
JP
Japan
Prior art keywords
composition according
days
compound
administered
clostridium difficile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018549896A
Other languages
English (en)
Japanese (ja)
Other versions
JP7458706B2 (ja
JP2019509318A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/023958 external-priority patent/WO2017165729A1/en
Publication of JP2019509318A publication Critical patent/JP2019509318A/ja
Priority to JP2022076605A priority Critical patent/JP2022115985A/ja
Priority to JP2023183167A priority patent/JP2024023187A/ja
Publication of JP2019509318A5 publication Critical patent/JP2019509318A5/ja
Application granted granted Critical
Publication of JP7458706B2 publication Critical patent/JP7458706B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018549896A 2016-03-24 2017-03-24 クロストリジウム・ディフィシル感染を処置及び予防するための方法 Active JP7458706B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022076605A JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2023183167A JP2024023187A (ja) 2016-03-24 2023-10-25 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662312996P 2016-03-24 2016-03-24
US62/312,996 2016-03-24
US201662320053P 2016-04-08 2016-04-08
US62/320,053 2016-04-08
PCT/US2017/023958 WO2017165729A1 (en) 2016-03-24 2017-03-24 Methods for treating and preventing c. difficile infection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022076605A Division JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Publications (3)

Publication Number Publication Date
JP2019509318A JP2019509318A (ja) 2019-04-04
JP2019509318A5 true JP2019509318A5 (https=) 2024-01-09
JP7458706B2 JP7458706B2 (ja) 2024-04-01

Family

ID=59900751

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018549896A Active JP7458706B2 (ja) 2016-03-24 2017-03-24 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2022076605A Pending JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2023183167A Pending JP2024023187A (ja) 2016-03-24 2023-10-25 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022076605A Pending JP2022115985A (ja) 2016-03-24 2022-05-06 クロストリジウム・ディフィシル感染を処置及び予防するための方法
JP2023183167A Pending JP2024023187A (ja) 2016-03-24 2023-10-25 クロストリジウム・ディフィシル感染を処置及び予防するための方法

Country Status (13)

Country Link
US (3) US20170319603A1 (https=)
EP (1) EP3432891A4 (https=)
JP (3) JP7458706B2 (https=)
CN (2) CN119454720A (https=)
AU (3) AU2017238644B2 (https=)
BR (2) BR122024000249A2 (https=)
CA (1) CA3018872A1 (https=)
MX (2) MX2018011413A (https=)
MY (1) MY197627A (https=)
PH (1) PH12018502020A1 (https=)
RU (1) RU2751509C1 (https=)
SG (2) SG11201808246SA (https=)
WO (1) WO2017165729A1 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017165729A1 (en) * 2016-03-24 2017-09-28 Paratek Pharmaceuticals, Inc. Methods for treating and preventing c. difficile infection
TW202206081A (zh) * 2016-08-03 2022-02-16 美商派瑞泰Ｓｐｖ２有限公司 ９—胺甲基米諾四環素化合物及其用途
BR112019008897A2 (pt) 2016-11-01 2019-08-13 Paratek Pharm Innc método para tratar pneumonia bacteriana adquirida na comunidade.
JP7110562B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP7110560B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP7110563B2 (ja) * 2017-09-06 2022-08-02 株式会社三洋物産 遊技機
JP2019136431A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
JP2019136430A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
JP2019136429A (ja) * 2018-02-15 2019-08-22 株式会社三洋物産 遊技機
CA3111447A1 (en) * 2018-09-04 2020-03-12 Paratek Pharmaceuticals, Inc. Methods of treating mycobacterial infections using tetracycline compounds
CN112823014A (zh) * 2018-10-10 2021-05-18 营养株式会社 艰难梭菌感染的预防和/或治疗剂
JP7840880B2 (ja) * 2020-06-11 2026-04-06 パラテック ファーマシューティカルズ，インコーポレイテッド オマダサイクリンの結晶形態、その合成方法及びその使用方法
PT117254B (pt) 2021-05-26 2024-04-18 Hovione Farm S A Método de síntese de compostos 9-aminometil tetraciclinas
JP2023105292A (ja) * 2022-07-21 2023-07-28 株式会社三洋物産 遊技機
JP2023105293A (ja) * 2022-07-21 2023-07-28 株式会社三洋物産 遊技機

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2113614A1 (en) * 1991-07-24 1993-02-04 Scott Donald Whalen Antimicrobial treatment methods and compositions
EA013908B1 (ru) * 2000-07-07 2010-08-30 Трастис Оф Тафтс Коллидж Замещенные соединения миноциклина (варианты), фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
US7553828B2 (en) * 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
EP2329826A1 (en) * 2001-07-13 2011-06-08 Paratek Pharmaceuticals, Inc. Tetracyclines for the treatment of multiple sclerosis
BRPI0620430A2 (pt) 2005-12-22 2011-11-08 Wyeth Corp métodos para tratar infecções do trato gastrointestinal com tigeciclina
EP2298324A1 (en) * 2006-01-24 2011-03-23 Paratek Pharmaceuticals, Inc. Methods of increasing oral bioavailability of tetracyclines
TW202216656A (zh) * 2008-05-19 2022-05-01 美商Ｐｒｔｋ Ｓｐｖ２公司 四環素化合物之甲苯磺酸鹽及同素異形體
WO2010093776A1 (en) * 2009-02-11 2010-08-19 Cedars-Sinai Medical Center Antibiotic therapy to reduce the likelihood of developing post-infectious irritable bowel syndrome
US8986697B2 (en) * 2010-04-15 2015-03-24 Progenics Pharmaceuticals, Inc. Antibodies for the treatment of Clostridium difficile-associated infection and disease
WO2012050826A1 (en) * 2010-09-29 2012-04-19 St. Jude Children's Research Hostpital Methods for treating clostridium difficile infections
WO2012065028A2 (en) * 2010-11-11 2012-05-18 Concert Pharmaceuticals Inc. Substituted tetracyclines
JP2016509003A (ja) * 2013-02-04 2016-03-24 セレス セラピューティクス インコーポレイテッド 組成物および方法
US20140274800A1 (en) * 2013-03-13 2014-09-18 Procarta Biosystems Ltd. Transcription factor decoys for the treatment and prevention of infections caused by bacteria including clostridium difficile
WO2017165729A1 (en) * 2016-03-24 2017-09-28 Paratek Pharmaceuticals, Inc. Methods for treating and preventing c. difficile infection

Similar Documents

Publication Publication Date Title
JP2019509318A5 (https=)
CN109311832A (zh) 沃替西汀的帕莫酸盐及其晶型
JP2014528901A5 (https=)
RU2010140682A (ru) Способ лечения пациента от инфекции, фармацевтическая композиция (варианты) и лекарственное средство
EA202191079A1 (ru) Способы лечения синдрома ретта с применением фенфлурамина
RU2015134581A (ru) Доноры нитроксила с улучшенным терапевтическим индексом
BRPI0512893A (pt) métodos de determinação da eficácia da terapia no tratamento da amiloidose e de identificação de paciente como prodrÈmico para doença associada com a deposição amilóide e respectivos compostos
RU2018103081A (ru) Способы лечения колитов
RU2017134443A (ru) Способ лечения с применением традипитанта
JP2020526553A5 (https=)
JP2017533972A5 (https=)
RU2016127558A (ru) Стероидное соединение для применения в лечении печеночной энцефалопатии
EA201791138A1 (ru) Фармацевтическая композиция, ее приготовление и применения
FI3801534T3 (fi) Fenyyliketonurian hoito sepiapteriinilla
EP4578461A3 (en) Methods of treating parkinsons disease by administration of apomorphine to an oral mucosa
JP2008534503A5 (https=)
JP2023549849A5 (https=)
MX2019001412A (es) Compuestos de 9-aminometil minociclina y usos de los mismos.
JP2023553253A5 (https=)
RU2016137926A (ru) Композиции грапипранта и способы их применения
RU2018130097A (ru) Лечение экземы кистей
JP2019535830A5 (https=)
FI3359572T3 (fi) Menetelmä multippeliskleroosin hoitamiseksi
LU82013A1 (fr) Nouvelles poudres lyophilisees contenant un sel de l'acide thiazolidine-4-carboxylique et leur procede de preparation
RU2018114457A (ru) Лечение syd985 пациентов с t-dm1 рефрактерным раком